Search

Patients who benefit

A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe…
Features

EXCEPTIONAL SAFETY4,5 MAXIMIZED EFFECTIVENESS4,5 LIFE-CHANGING IMPACT3-5 The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2…
Clinical Data-Backup

THE FIRST CHOICE TO RESTORE THE TRICUSPID VALVE1 TriClip TEER has shown meaningful outcomes in both real-world and randomized clinical data. bRIGHT and TRILUMINATE™ Pivotal Trials demonstrated the…
Patients who benefit-Backup

A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe…
Overview-Backup

WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE FIND OUT MORE: DOWNLOAD FLYER SPECIALLY DESIGNED FOR THE TRICUSPID VALVE1 TriClip™ Transcatheter Edge-to-Edge (TEER) offers unmatched…
LAAO Summit 2023

ON DEMAND - LAAO SUMMIT 2023 12th Global Left Atrial Appendage Occlusion Summit LAAO SUMMIT 2023 - Welcome Left Atrial Appendage Occlusion therapy has become an established and increasingly…
Patients who benefit

SWITCH TO THE REFERRAL VIEW For more information specific to neurology regarding LAA Occlusion Life-long medication to reduce stroke risk is not an option for many patients. The…
Connext Live

© Abbott 2023. All rights reserved. 9-EH-5-14560-01 09-2023
Clinical Data

GREATER SAFETY COMPARED WITH SURGICAL CLOSURE The Amplatzer™ Septal Occluder is the most studied transcatheter atrial septal defect (ASD) closure device available today, with over 25+ years of…
Clinical Data

SURGICAL VALVE SOLUTIONS DURABILITY THAT WITHSTANDS THE LONG-TERM TEST OF TIME 10 YEARS 93.8%* Freedom from SVD, All patient ages (Epic™ Mitral Valve)1 96.3%* Freedom from SVD, All patient…